Both in Biotechnology
Tevogen vs Metagenomi Therapeutics
Over the past year TVGN returned −82.9% and MGX returned −50.9%; their daily moves had a correlation of 0.15.
TVGN −82.9% MGX −50.9%Growth of $1, one year, split-adjusted
| Metric | TVGN | MGX |
|---|---|---|
| Price | $6.75 | $1.13 |
| Market cap | $44.0M | $42.7M |
| Today | −0.15% | −0.88% |
| 1 month | −2.0% | −5.0% |
| 6 months | +57.3% | −10.7% |
| Year to date | −59.2% | −30.2% |
| 1 year | — | −50.7% |
| Revenue growth (YoY) | — | −103.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 3.1× |
| Net cash | -$7.0M | $120.7M |
| Dividend yield | — | — |
| Volatility (60d) | 80.4% | 27.2% |
| Short % of float | 4.1% | 6.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).